OPV (Oral Polio Vaccine) bivalent Type 1 & 3 (20 dose vial)
Vaccine Trade Name: Oral bivalent types 1 & 3 poliomyelitis vaccine
Vaccine Type: OPV (Oral Polio Vaccine) bivalent Type 1 & 3
Manufacturer: Sanofi Pasteur
Country of Manufacture: France
Date of prequalification: 2 August 2011
NRA of Record: ANSM
Product Description
Pharmaceutical form: liquid
Presentation: 20 dose vial
Route of administration: oral
Vaccine Vial Monitor: Type 2
Shelf life: 24 months at - 20 °C
Secondary Packaging: carton of 10 vials
Cold Chain volume per dose (cm3): 2.41
Preservative: None.
Handling of opened multi-dose vials: WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.
Remarks